Journal
JOURNAL OF THE NEUROLOGICAL SCIENCES
Volume 301, Issue 1-2, Pages 1-8Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jns.2010.10.033
Keywords
B-12 deficiency; Myelopathy; Nitrous oxide; Cytokine
Categories
Ask authors/readers for more resources
Beginning with a case report of nitrous oxide (N2O)-induced B-12 deficiency myelopathy, this article reviews the clinical biochemistry of vitamin B-12, and examines the pathogenetic mechanisms by which B-12 deficiency leads to neurologic damage, and how this damage is potentiated by N2O exposure. The article systematically examines the available experimental data relating to the two main coenzyme mechanisms that are usually suggested in clinical articles, particularly the deficient methylation hypothesis. The article demonstrates that neither of these mechanisms is fully consistent with the available data. The article then presents a novel mechanism based on new data from the neuroimmunology basic science literature which suggests that the pathogenesis of B-12 deficiency myelopathy may not be related to its role as a coenzyme, but rather to newly discovered functions of B-12 in regulating cytokines and growth factors. (C) 2010 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available